IL-13 suppresses double-stranded RNA-induced IFN-λ production in lung cells

Biochemical and Biophysical Research Communications

Volumn 404, Issue 4, 2011, Pages 922-927

  Moriwaki, Atsushi ^a   Matsumoto, Koichiro ^a   Matsunaga, Yuko ^a   Fukuyama, Satoru ^a   Matsumoto, Takafumi ^a   Kan o, Keiko ^a   Noda, Naotaka ^a   Asai, Yukari ^a   Nakanishi, Yoichi ^a   Inoue, Hiromasa ^a,b  

^a KYUSHU UNIVERSITY   (Japan)

^b KAGOSHIMA UNIVERSITY   (Japan)

Author keywords

Alveolar macrophages; Bronchial epithelial cells; DsRNA; IFN ; IL 13

Indexed keywords

DOUBLE STRANDED RNA; INTERFERON; INTERFERON LAMBDA; INTERLEUKIN 13; N BENZYL 2 CYANO 3 (3,4 DIHYDROXYPHENYL)ACRYLAMIDE; RETINOIC ACID INDUCIBLE PROTEIN I; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASTHMA; CONTROLLED STUDY; IN VITRO STUDY; INTERFERON PRODUCTION; LUNG ALVEOLUS CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; WILD TYPE;

ANIMALS; ASTHMA; CELL LINE; HUMANS; INTERFERON-GAMMA; INTERLEUKIN-13; LUNG; MACROPHAGES, ALVEOLAR; MICE; MICE, MUTANT STRAINS; POLY I-C; RESPIRATORY MUCOSA; RNA, DOUBLE-STRANDED; VIRUS DISEASES;

MUS;

EID: 79151476446     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2010.12.082     Document Type: Article

References (37)

1. Roche W.R., Beasley R., Williams J.H., Holgate S.T. Subepithelial fibrosis in the bronchi of asthmatics. Lancet 1989, 1:520-524.
2. Elias J.A., Lee C.G., Zheng T., Ma B., Homer R.J., Zhu Z. New insights into the pathogenesis of asthma. J. Clin. Invest. 2003, 111(2003):291-297.
3. Kibe A., Inoue H., Fukuyama S., Machida K., Matsumoto K., Koto H., Ikegami T., Aizawa H., Hara N. Differential regulation by glucocorticoid of interleukin-13-induced eosinophilia, hyperresponsiveness, and goblet cell hyperplasia in mouse airways. Am. J. Respir. Crit. Care Med. 2003, 167(2003):50-56.
4. Grunig G., Warnock M., Wakil A.E., Venkayya R., Brombacher F., Rennick D.M., Sheppard D., Mohrs M., Donaldson D.D., Locksley R.M., Corry D.B. Requirement for IL-13 independently of IL-4 in experimental asthma. Science 1998, 282:2261-2263.
5. Wills-Karp M., Luyimbazi J., Xu X., Schofield B., Neben T.Y., Karp C.L., Donaldson D.D. Interleukin-13: central mediator of allergic asthma. Science 1998, 282:2258-2261.
6. Beasley R., Coleman E.D., Hermon Y., Holst P.E., O'Donnell T.V., Tobias M. Viral respiratory tract infection, exacerbations of asthma in adult patients. Thorax 1988, 43:679-683.
7. Chauhan A.J., Inskip H.M., Linaker C.H., Smith S., Schreiber J., Johnston S.L., Holgate S.T. Personal exposure to nitrogen dioxide (NO2) and the severity of virus-induced asthma in children. Lancet 2003, 361:1939-1944.
8. Nicholson K.G., Kent J., Ireland D.C. Respiratory viruses and exacerbations of asthma in adults. Br. Med. J. 1993, 307:982-986.
9. Akira S., Uematsu S., Takeuchi O. Pathogen recognition and innate immunity. Cell 2006, 124:783-801.
10. Alexopoulou L., Holt A.C., Medzhitov R., Flavell R.A. Recognition of double-stranded RNA, activation of NF-kappaB by Toll-like receptor 3. Nature 2001, 413:732-738.
11. Kato H., Takeuchi O., Sato S., Yoneyama M., Yamamoto M., Matsui K., Uematsu S., Jung A., Kawai T., Ishii K.J., Yamaguchi O., Otsu K., Tsujimura T., Koh C.S., Reis e Sousa C., Matsuura Y., Fujita T., Akira S. Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses. Nature 2006, 441:101-105.
12. Yoneyama M., Kikuchi M., Natsukawa T., Shinobu N., Imaizumi T., Miyagishi M., Taira K., Akira S., Fujita T. The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses. Nat. Immunol. 2004, 5(2004):730-737.
13. Oshiumi H., Matsumoto M., Funami K., Akazawa T., Seya T. TICAM-1, an adaptor molecule that participates in Toll-like receptor 3-mediated interferon-beta induction. Nat. Immunol. 2003, 4:161-167.
14. Yamamoto M., Sato S., Hemmi H., Hoshino K., Kaisho T., Sanjo H., Takeuchi O., Sugiyama M., Okabe M., Takeda K., Akira S. Role of adaptor TRIF in the MyD88-independent toll-like receptor signaling pathway. Science 2003, 301:640-643.
15. Kawai T., Takahashi T.K., Sato S., Coban C., Kumar H., Kato H., Ishii K.J., Takeuchi O., Akira S. IPS-1, an adaptor triggering RIG-I- and Mda5-mediated type I interferon induction. Nat. Immunol. 2005, 6(2005):981-988.
16. Meylan E., Curran J., Hofmann K., Moradpour D., Binder M., Bartenschlager R., Tschopp J. Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus. Nature 2005, 437(2005):1167-1172.
17. Seth R.B., Sun L., Ea C.K., Chen Z.J. Identification, characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF-kappaB and IRF-3. Cell 2005, 122:669-682.
18. Xu L.G., Wang Y.Y., Han K.J., Li L.Y., Zhai Z., Shu H.B. VISA is an adapter protein required for virus-triggered IFN-beta signaling. Mol. Cell 2005, 19(2005):727-740.
19. Kotenko S.V., Gallagher G., Baurin V.V., Lewis-Antes A., Shen M., Shah N.K., Langer J.A., Sheikh F., Dickensheets H., Donnelly R.P. IFN-lambdas mediate antiviral protection through a distinct class II cytokine receptor complex. Nat. Immunol. 2003, 4:69-77.
20. Contoli M., Message S.D., Laza-Stanca V., Edwards M.R., Wark P.A., Bartlett N.W., Kebadze T., Mallia P., Stanciu L.A., Parker H.L., Slater L., Lewis-Antes A., Kon O.M., Holgate S.T., Davies D.E., Kotenko S.V., Papi A., Johnston S.L. Role of deficient type III interferon-lambda production in asthma exacerbations. Nat. Med. 2006, 12:1023-1026.
21. Corne J.M., Marshall C., Smith S., Schreiber J., Sanderson G., Holgate S.T., Johnston S.L. Frequency, severity, and duration of rhinovirus infections in asthmatic and non-asthmatic individuals: a longitudinal cohort study. Lancet 2002, 359:831-834.
22. Kumar S., Lindorfer R.K. The characterization of staphylococcal toxins. I. The electrophoretic migration of the alpha hemolytic, dermonecrotic, lethal, and leucocidal activities of crude toxin. J. Exp. Med. 1962, 115(1962):1095-1106.
23. McKenzie G.J., Bancroft A., Grencis R.K., McKenzie A.N. A distinct role for interleukin-13 in Th2-cell-mediated immune responses. Curr. Biol. 1998, 8:339-342.
24. Inoue H., Kato R., Fukuyama S., Nonami A., Taniguchi K., Matsumoto K., Nakano T., Tsuda M., Matsumura M., Kubo M., Ishikawa F., Moon B.G., Takatsu K., Nakanishi Y., Yoshimura A. Spred-1 negatively regulates allergen-induced airway eosinophilia and hyperresponsiveness. J. Exp. Med. 2005, 201:73-82.
25. Li M.C., Wang H.Y., Wang H.Y., Li T., He S.H. Liposome-mediated IL-28 and IL-29 expression in A549 cells and anti-viral effect of IL-28 and IL-29 on WISH cells. Acta. Pharmacol. Sin. 2006, 27:453-459.
26. Meylan E., Tschopp J. Toll-like receptors, RNA Helicases: two parallel ways to trigger antiviral responses. Mol. Cell 2006, 22:561-569.
27. Lasfar A., Lewis-Antes A., Smirnov S.V., Anantha S., Abushahba W., Tian B., Reuhl K., Dickensheets H., Sheikh F., Donnelly R.P., Raveche E., Kotenko S.V. Characterization of the mouse IFN-lambda ligand-receptor system: IFN-lambdas exhibit antitumor activity against B16 melanoma. Cancer Res. 2006, 66:4468-4477.
28. Kelly-Welch A.E., Hanson E.M., Boothby M.R., Keegan A.D. Interleukin-4 and interleukin-13 signaling connections maps. Science 2003, 300:1527-1528.
29. Nakano T., Inoue H., Fukuyama S., Matsumoto K., Matsumura M., Tsuda M., Matsumoto T., Aizawa H., Nakanishi Y. Niflumic acid suppresses interleukin-13-induced asthma phenotypes. Am. J. Respir. Crit. Care Med. 2006, 173:1216-1221.
30. Howell M.D., Gallo R.L., Boguniewicz M., Jones J.F., Wong C., Streib J.E., Leung D.Y. Cytokine milieu of atopic dermatitis skin subverts the innate immune response to vaccinia virus. Immunity 2006, 24:341-348.
31. Mueller T., Terada T., Rosenberg I.M., Shibolet O., Podolsky D.K. Th2 cytokines down-regulate TLR expression and function in human intestinal epithelial cells. J. Immunol. 2006, 176:5805-5814.
32. Wang Q., Nagarkar D.R., Bowman E.R., Schneider D., Gosangi B., Lei J., Zhao Y., McHenry C.L., Burgens R.V., Miller D.J., Sajjan U., Hershenson M.B. Role of double-stranded RNA pattern recognition receptors in rhinovirus-induced airway epithelial cell responses. J. Immunol. 2009, 183:6989-6997.
33. Takeuchi O., Akira S. Innate immunity to virus infection. Immunol. Rev. 2009, 227:75-86.
34. Wang S.Z., Xu H., Wraith A., Bowden J.J., Alpers J.H., Forsyth K.D. Neutrophils induce damage to respiratory epithelial cells infected with respiratory syncytial virus. Eur. Respir. J. 1998, 12:612-618.
35. Bossios A., Psarras S., Gourgiotis D., Skevaki C.L., Constantopoulos A.G., Saxoni-Papageorgiou P., Papadopoulos N.G. Rhinovirus infection induces cytotoxity and delays wound healing in bronchial epithelial cells. Respir. Res. 2005, 10:114.
36. Allahverdian S., Harada N., Singhera G.K., Nnight D.A., Dorscheid D.R. Secretion of IL-13 by airway epithelial cells enhances epithelial repair via HB-EGF. Am. J. Respir. Cell Mol. Biol. 2008, 38:153-160.
37. R.J. Freishtat, A.M. Watson, A.S. Benton, S.F. Iqbal, D.K. Pillai, M.C. Rose, E.P. Hoffman. Asthmatic airway epithelium is intrinsically inflammatory and mitotically dyssynchronous. Am. J. Respir. Cell Mol. Biol. (2011) (Epub ahead of print).